|
|
|
|
|
|
|
David Biondi, DO Therapeutic Area Lead, Neuroscience Insights & Innovation
US Medical Affairs
Janssen Scientific Affairs, LLC
Chairperson, Academic and Research Affairs
University of New England
|
| |
|
|
|
Cathryn M. Clary, MD Head, US Medical & Chief Scientific Officer, Novartis, Board, Association of the Accreditation of Human Research Protection Programs, Distinguished Fellow, American Psychiatric Association
|
| |
|
|
|
|
|
|
|
|
|
|
Tim Grimes Health Care Compliance Officer, North American Pharmaceuticals
Johnson & Johnson
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Randy Miller, PharmD, RPh Director, Field Based Medicine Operations
Clinical Development & Medical Affairs
Boehringer Ingelheim Pharmaceuticals, Inc.
|
| |
|
|
|
|
Tomas J. Philipson, PhD Daniel Levin Professor of Public Policy, Irving B. Harris Graduate School of Public Policy Studies, University of Chicago
Former Senior Economic Advisor, FDA
Former Senior Economic Advisor, CMS
Member, Key National Indicator Commission
Founding Editor, Forums for Health Economics & Policy
Chairperson, Project FDA, The Manhattan Institute
|
| |
|
|
|
|
Cliff Saffron, JD Principal, Life Sciences Advisory Practice
KPMG LLP
Former Senior Vice President, General Counsel
ImClone Systems
|
| |
|
|
|
|
|
Eric Silfen, MD Senior Vice President and Chief Medical Officer, Philips Healthcare, Board, International Biomedical Research Alliance, Member, American Medical Informatics Association, Member, The New York Academy of Sciences
|
| |
|
|
|
|
Thomas Sullivan President, Rockpointe
Editor, Policy and Medicine
Co-founder, Association of Clinical Researchers and Educators
|
| |
|
|
|
|
Christine Wyble, PharmD Global Head, Medical Science Liaisons and Medical Information
Oncology Global Development and Global Medical Affairs
Novartis Pharmaceuticals Corporation
|
| |
|